Apply for a Grant

Open Funding Opportunity

Bringing breakthrough regenerative medicine therapies to Minnesotans

 

Application submission deadline: Thursday, October 22, 2026 at 1pm CT.

Link for Online Submission form: https://umnodat.infoready4.com/#freeformCompetitionDetail/2032182

 

The mission of Regenerative Medicine Minnesota (RMM) is to bring breakthrough regenerative medicine therapies to Minnesotans and patients worldwide. Achieving this vision requires not only advancing novel therapies, but also the innovations, capabilities, collaborations and pathways that enable them to ultimately reach patients. Recognizing the need for a multi-pronged innovation strategy, RMM is calling for proposals that align with this vision through the 2027 Request for Proposals (RFP). By strategically investing across these areas, RMM aims to accelerate transformative regenerative medicine therapies, strengthen Minnesota's leadership in regenerative medicine and generate lasting health and economic benefits for Minnesotans.   

This RFP is designed to solicit projects that are aligned with one or more of the following objectives:

  1. Advance novel regenerative medicine therapies and products towards clinical application. Proposed therapies or products should have a clearly defined target use, indication or disease area.
  2. Develop enabling innovations and platforms that improve the ability to discover, develop, manufacture, or deliver regenerative medicine therapies across multiple applications.
  3. Build sustainable capabilities and infrastructure that accelerate clinical translation and commercialization in Minnesota.
  4. Foster collaborations across institutions and sectors that strengthen Minnesota’s regenerative medicine ecosystem.
  5. Expand patient access to regenerative medicine therapies to benefit patients across Minnesota, including greater Minnesota.

Particular areas of interest for funding under this RFP include, but are not limited to:

  • Platform-based approaches that can be applied to many diseases, particularly rare diseases, such as gene editing/replacement strategies, therapeutic approaches, delivery methods, manufacturing models, regulatory strategies, clinical trial designs, etc.
  • Device-enabled regenerative medicine innovations such as biologic/cell-device combination therapeutics, biomanufacturing devices or tools, therapeutic delivery, etc.
  • Strategies to improve immune compatibility and therapeutic durability, including promoting immune tolerance or reducing immune rejection.

 

For examples of funded projects from previous RFP cycles see here.

 

Contact RegenMedMN@gmail.com with any questions.

 

Want to receive notifications about grant application announcements and deadlines?

  • Fill out our contact form and request to be included on our email distribution list.
  • Before applying for a grant, be sure to read the RFP.
  • Have a question? Send us an email.